Watch ICUCW. Know when insiders buy.
One email the day a filing lands. Free.
ICUCW
SeaStar Medical Holding Corp
No price history available
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
46
WATCH · shorts 46
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM $1.7M +123.6%NET INCOME −$13.6MNET CASH $52K52W —SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $615K | +82.0% | 91.2% | −$3.8M | −$3.7M | — | -0.91 | −$3M | — | — | Aug 12 |
| Q1 2026 · Mar 31 | $495K | +68.9% | 90.7% | −$3.6M | −$3.5M | — | -0.90 | −$2.8M | — | — | Aug 12 |
| Q4 2025 · Dec 31derived | $420K | +526.9% | 97.1% | −$3M | −$2.9M | — | -5.26 | −$4.1M | — | — | Mar 25 |
| Q3 2025 · Sep 30 | $183K | +169.1% | 92.3% | −$3.6M | −$3.5M | — | -0.13 | −$3.8M | — | — | Nov 13 |
| Q2 2025 · Jun 30 | $338K | — | 92.0% | −$1.8M | −$2M | — | -0.18 | −$3M | — | — | Aug 12 |
| Q1 2025 · Mar 31 | $293K | — | 100.0% | −$3.8M | −$3.8M | — | -0.44 | −$2.7M | — | — | Aug 12 |
| Q4 2024 · Dec 31derived | $67K | — | 100.0% | −$4.8M | −$4.4M | — | -0.53 | −$4.7M | — | — | Mar 25 |
| Q3 2024 · Sep 30 | $68K | — | 100.0% | −$4.5M | −$4.5M | — | -1.10 | −$5M | — | — | Nov 13 |
| Q2 2024 · Jun 30 | $0 | — | — | −$4.7M | −$3.2M | — | -1.03 | −$2.8M | — | — | Nov 13 |
| Q1 2024 · Mar 31 | $0 | — | — | −$4M | −$12.7M | — | -4.73 | −$3.5M | — | — | Nov 13 |
| Q4 2023 · Dec 31derived | $0 | — | — | −$2.9M | −$9.5M | — | -4.10 | −$4.5M | — | — | Mar 27 |
| Q3 2023 · Sep 30 | $0 | — | — | −$2.9M | −$7.2M | — | -9.02 | −$1.3M | — | — | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.2M | 95.7% | −$12.2M | −$12.2M | -984.6% | -5.86 | −$13.6M | — | — | — | — |
| FY2024 · to Dec 31 | $135K | 100.0% | −$17.8M | −$24.8M | -18392.6% | -6.63 | −$16M | — | — | — | — |
| FY2023 · to Dec 31 | $0 | — | −$14.2M | −$26.2M | — | -30.26 | −$10.3M | — | — | — | — |
| FY2022 · to Dec 31 | — | — | −$11.6M | −$12.2M | — | -1.48 | −$7.8M | — | — | — | — |
| FY2021 · to Dec 31 | — | — | −$4.4M | −$4.6M | — | -0.63 | −$5.1M | — | — | — | — |
Every number comes from SeaStar Medical Holding Corp's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.